Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device

European Journal of Heart Failure

Volumn 16, Issue 8, 2014, Pages 871-879

  Morley Smith, Andrew C ^a,b,d   Mills, Adam ^b,d   Jacobs, Steven ^c   Meyns, Bart ^c   Rega, Filip ^c   Simon, André R ^a,b   Pepper, John R ^a,b   Lyon, Alexander R ^a,b   Thum, Thomas ^b,d  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Biomarker; MicroRNA; Ventricular assist device

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ADULT; ARTICLE; ASSISTED CIRCULATION; BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HEART MUSCLE; HUMAN; HUMAN CELL; LEFT VENTRICULAR ASSIST DEVICE; MALE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT RESPONSE; UPREGULATION; VENTRICULAR ASSIST DEVICE; CARDIAC MUSCLE; HEART ASSIST DEVICE; HEART FAILURE; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; BIOMARKERS; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIUM; TREATMENT OUTCOME;

EID: 84905706249     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.116     Document Type: Article

References (27)

1. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Timothy Baldwin J, Young JB,. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 2013; 32: 141-156.
2. Sharples LD, Dyer M, Cafferty F, Demiris N, Freeman C, Banner NR, Large SR, Tsui S, Caine N, Buxton M,. Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK). J Heart Lung Transplant 2007; 26: 9 -15.
3. Clegg AJ, Scott DA, Loveman E, Colquitt J, Royle P, Bryant J,. Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation. Int J Technol Assess Health Care 2007; 23: 261-268.
4. Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, Morgan JA, Arabia F, Bauman ME, Buchholz HW, Deng M, Dickstein ML, El-Banayosy A, Elliot T, Goldstein DJ, Grady KL, Jones K, Hryniewicz K, John R, Kaan A, Kusne S, Loebe M, Massicotte MP, Moazami N, Mohacsi P, Mooney M, Nelson T, Pagani F, Perry W, Potapov EV, Eduardo Rame J, Russell SD, Sorensen EN, Sun B, Strueber M, Mangi AA, Petty MG, Rogers J, International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013; 32: 157-187.
5. Thum T,. MicroRNA therapeutics in cardiovascular medicine. EMBO Mol Med 2012; 4: 3-14.
6. Kumarswamy R, Thum T,. Non-coding RNAs in cardiac remodeling and heart failure. Circ Res 2013; 113: 676-689.
7. Small EM, Olson EN,. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011; 469: 336-342.
8. Matkovich SJ, Van Booven DJ, Youker KA, Torre-Amione G, Diwan A, Eschenbacher WH, Dorn LE, Watson MA, Margulies KB, Dorn GW 2nd,. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 2009; 119: 1263-1271.
9. Ramani R, Vela D, Segura A, McNamara D, Lemster B, Samarendra V, Kormos R, Toyoda Y, Bermudez C, Frazier OH, Moravec CS, Gorcsan J 3rd, Taegtmeyer H, McTiernan CF,. A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol 2011; 58: 2270-2278.
10. Tijsen AJ, Pinto YM, Creemers EE,. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol 2012; 303: H1085-H1095.
11. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM,. MiR423-5p as a circulating biomarker for heart failure. Circ Res 2010; 106: 1035-1039.
12. Goren Y, Kushnir M, Zafrir B, Tabak S, Lewis BS, Amir O,. Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 2012; 14: 147-154.
13. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, Kempf T, Wollert KC, Thum T,. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011; 51: 872-875.
14. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH, HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-2251.
15. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, Jessup ML, Gregoric ID, Loyalka P, Frazier OH, Jeevanandam V, Anderson AS, Kormos RL, Teuteberg JJ, Levy WC, Naftel DC, Bittman RM, Pagani FD, Hathaway DR, Boyce SW,. HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012; 125: 3191-3200.
16. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR,. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83: 778-786.
17. Levy WC, Mozaffarian D, Linker DT, Farrar DJ, Miller LW, REMATCH Investigators. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant 2009; 28: 231-236.
18. Shah NR, Cevik C, Hernandez A, Gregoric ID, Frazier OH, Stainback RF,. Transthoracic echocardiography of the HeartWare left ventricular assist device. J Card Fail 2012; 18: 745-748.
19. Sareyyupoglu B, Boilson BA, Durham LA, McGregor CG, Daly RC, Redfield MM, Edwards BS, Frantz RP, Pereira NL, Park SJ,. B-type natriuretic peptide levels and continuous-flow left ventricular assist devices. ASAIO J 2010; 56: 527-531.
20. George RS, Sabharwal NK, Webb C, Yacoub MH, Bowles CT, Hedger M, Khaghani A, Birks EJ,. Echocardiographic assessment of flow across continuous-flow ventricular assist devices at low speeds. J Heart Lung Transplant 2010; 29: 1245-1252.
21. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG, UCAR (Utah Cardiac Recovery Program) Investigators. Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol 2013; 61: 1985-1994.
22. Kaudewitz D, Lee R, Willeit P, McGregor R, Markus HS, Kiechl S, Zampetaki A, Storey RF, Channon KM, Mayr M,. Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease. Thromb Haemost 2013; 110: 609-615.
23. Mayr M, Lee R, Kaudewitz D, Zampetaki A, Channon KM,. Effects of heparin on temporal microRNA profiles. J Am Coll Cardiol 2014; 63: 941-942.
24. Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, Kirkby NS, Crosby-Nwaobi R, Prokopi M, Drozdov I, Langley SR, Sivaprasad S, Markus HS, Mitchell JA, Warner TD, Kiechl S, Mayr M,. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res 2013; 112: 595-600.
25. de Lemos JA, McGuire DK, Drazner MH,. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-322.
26. Mohapatra B, Vick GW 3rd, Fraser CD Jr, Clunie SK, Towbin JA, Sinagra G, Vatta M,. Short-term mechanical unloading and reverse remodeling of failing hearts in children. J Heart Lung Transplant 2010; 29: 98-104.
27. Marin T1, Gongol B, Chen Z, Woo B, Subramaniam S, Chien S, Shyy JY,. Mechanosensitive microRNAs-role in endothelial responses to shear stress and redox state. Free Radic Biol Med 2013;64:6